The new platform helped UC San Diego scientists synthesize 32 potential multi-target cancer drugs.
Scientists at UC San Diego have developed a machine learning algorithm to simulate the time-consuming chemistry involved in the earliest phases of drug discovery, which could significantly streamline the process and open doors for never-before-seen treatments. Identifying candidate drugs for further optimization typically involves thousands of individual experiments, but the new artificial intelligence (AI) platform could potentially give the same results in a fraction of the time.
The researchers used the new tool, described today (May 6) in Nature Communications, to synthesize 32 new drug candidates for cancer.
The Shift Toward AI in Pharmaceuticals
The technology is part of a new but growing trend in pharmaceutical science of using AI to improve drug discovery and development.
“A few years ago, AI was a dirty word in the pharmaceutical industry, but now the trend is definitely the opposite, with biotech startups finding it difficult to raise funds without addressing AI in their business plan,” said senior author Trey Ideker, professor in the Department of Medicine at UC San Diego School of Medicine and adjunct professor of bioengineering and computer science at the UC San Diego Jacobs School of Engineering. “AI-guided drug discovery has become a very active area in industry, but unlike the methods being developed in companies, we’re making our technology open source and accessible to anybody who wants to use it.”
Advantages of Multi-Target Drug Discovery
The new platform, called POLYGON, is unique among AI tools for drug discovery in that it can identify molecules with multiple targets, while existing drug discovery protocols currently prioritize single target therapies. Multi-target drugs are of major interest to doctors and scientists because of their potential to deliver the same benefits as combination therapy, in which several different drugs are used together to treat cancer, but with fewer side effects.
“It takes many years and millions of dollars to find and develop a new drug, especially if we’re talking about one with multiple targets.” said Ideker. “The rare few multi-target drugs we do have were discovered largely by chance, but this new technology could help take chance out of the equation and kickstart a new generation of precision medicine.”
How POLYGON Works
The researchers trained POLYGON on a database of over a million known bioactive molecules containing detailed information about their chemical properties and known interactions with protein targets. By learning from patterns found in the database, POLYGON is able to generate original chemical formulas for new candidate drugs that are likely to have certain properties, such as the ability to inhibit specific proteins.
“Just like AI is now very good at generating original drawings and pictures, such as creating pictures of human faces based off desired properties like age or sex, POLYGON is able to generate original molecular compounds based off of desired chemical properties,” said Ideker. “In this case, instead of telling the AI how old we want our face to look, we’re telling it how we want our future drug to interact with disease proteins.”
Testing and Results
To put POLYGON to the test, the researchers used it to generate hundreds of candidate drugs that target various pairs of cancer-related proteins. Of these, the researchers synthesized 32 molecules that had the strongest predicted interactions with the MEK1 and mTOR proteins, a pair of cellular signaling proteins that are a promising target for cancer combination therapy. These two proteins are what scientists call synthetically lethal, which means that inhibiting both together is enough to kill cancer cells even if inhibiting one alone is not.
The researchers found that the drugs they synthesized had significant activity against MEK1 and mTOR, but had few off-target reactions with other proteins. This suggests that one or more of the drugs identified by POLYGON could be able to target both proteins as a cancer treatment, providing a list of choices for fine-tuning by human chemists.
“Once you have the candidate drugs, you still need to do all the other chemistry it takes to refine those options into a single, effective treatment,” said Ideker. “We can’t and shouldn’t try to eliminate human expertise from the drug discovery pipeline, but what we can do is shorten a few steps of the process.”
Future of AI in Drug Discovery
Despite this caution, the researchers are optimistic that the possibilities of AI for drug discovery are only just being explored.
“Seeing how this concept plays out over the next decade, both in academia and in the private sector, is going to be very exciting,” said Ideker. “The possibilities are virtually endless.”
Reference: 6 May 2024,
Co-authors of the study include: Brenton Munson, Michael Chen, Audrey Bogosian, Jason Kreisberg, Katherine Licon, Abagyan Ruben and Brent Kuenzi, all at UC San Diego.
This study was funded, in part, by the National Institutes of Health (Grants CA274502, GM103504, ES014811, CA243885, CA212456).
News
Unlocking Cancer’s Code: Johns Hopkins Researchers Reveal How Cells Go Rogue
Scientists at Johns Hopkins Medicine have mapped a molecular pathway in human breast and lung cells that could lead to excessive genome duplication, a hallmark of cancer cells. The findings, recently published in the journal Science, reveal [...]
Scientists Uncover Unexpected Hidden Dangers of a Common Antibiotic
In emergency rooms and intensive care units nationwide, healthcare professionals must quickly decide on antibiotics for patients suspected of having severe infections. A recent study from the University of Michigan indicates that these rapid decisions could [...]
New research to make digital transactions quantum safe and 20 times faster
A team of experts, including Monash University researchers, has developed a new technique to implement quantum-safe digital signatures twenty times faster, resulting in speedier and safer online transactions than ever before. The research, published recently [...]
Scientists use generative AI to answer complex questions in physics
When water freezes, it transitions from a liquid phase to a solid phase, resulting in a drastic change in properties like density and volume. Phase transitions in water are so common most of us [...]
An easy pill to swallow—new 3D printing research paves way for personalized medication
A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalized pills that can deliver timed doses. Researchers from the University of [...]
Revolutionary “Quartet Nanocage” Vaccine Effective Against Coronaviruses That Haven’t Even Emerged Yet
Researchers have created a new vaccine technology that, in tests with mice, has demonstrated protection against a wide variety of coronaviruses, including those that could cause future disease outbreaks—even those not yet identified. This [...]
Researchers Warn: AI Systems Have Already Learned How To Deceive Humans
Numerous artificial intelligence (AI) systems, even those designed to be helpful and truthful, have already learned how to deceive humans. In a review article recently published in the journal Patterns, researchers highlight the dangers of [...]
MIT’s New MRI Technique Reveals Hidden Light Deep in the Brain
A novel MRI technique developed at MIT allows for detailed imaging of bioluminescence deep within the brain, offering new insights into how brain cells develop and communicate with each other. Scientists often label cells with proteins [...]
Revolutionary mRNA Cancer Vaccine Shows Immense Promise in First-Ever Human Clinical Trial
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the University of Florida rapidly reprogrammed the immune system to target glioblastoma, the deadliest and most aggressive form of brain [...]
Human brain map contains never-before-seen details of structure
A cubic millimeter of brain tissue may not sound like much. But considering that tiny square contains 57,000 cells, 230 millimeters of blood vessels, and 150 million synapses, all amounting to 1,400 terabytes of [...]
AI Ethics Surpass Human Judgment in New Moral Turing Test
AI’s ability to address moral questions is improving, which prompts further considerations for the future. A recent study revealed that when individuals are given two solutions to a moral dilemma, the majority tend to [...]
AstraZeneca removes its Covid vaccine worldwide after rare side effect
AstraZeneca withdraws COVID-19 vaccine: The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side [...]
AI Transforms Drug Discovery With Faster, Safer Cancer Treatments
The new platform helped UC San Diego scientists synthesize 32 potential multi-target cancer drugs. Scientists at UC San Diego have developed a machine learning algorithm to simulate the time-consuming chemistry involved in the earliest phases of [...]
Nanotech opens door to future of insulin medication
An international team, led by researchers from Australia, have developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future. The researchers say the new insulin could [...]
COVID-19’s Impact on Child Development More Subtle Than Expected
Researchers at Johns Hopkins Children’s Center express that the study results offer a sense of reassurance, instilling “guarded optimism” regarding the developmental outcomes of young children who have been exposed to restrictions stemming from [...]
New Hope for Neurological Disorders: Scientists Have Discovered How an Essential Nutrient Enters the Brain
Researchers have discovered the process by which dietary choline crosses the blood-brain barrier. This breakthrough has potential applications in enhancing drug delivery to the brain for treating neurological disorders. A researcher from the University of [...]